The Harvard Gazette

Lynda Chin

Page 1 of 1

"Early-stage melanomas are often cured by surgical removal, but in about 10 percent of patients who undergo surgery and are considered cancer-free, the disease recurs in metastatic form and becomes fatal," says Lynda Chin, a Harvard Medical School professor. "The goal of this study was to see if we could find genetic events within the tumor cells that indicate which patients are at high risk for metastasis." Pictured is advanced malignant melanoma.

Predicting cancer’s spread

Some early-stage melanoma tumors offer clues to recurrence

Health|

DateJuly 15, 2011July 26, 2019

Study pinpoints novel cancer gene and biomarker

Research underscores need to combine genomics and basic biology in cancer gene hunt

Health|

DateJune 24, 2009

Study sheds light on how the sun causes skin cancer

Findings could lead to new methods for diagnosing early melanoma

Health|

DateJanuary 30, 2003